Avoro Capital Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,000,000	Closed	-$810M	–	51
2023 Q3	$810M	Hold	7,000,000	–	–	12.63%	1
2023 Q2	$720M	Hold	7,000,000	–	–	9.77%	2
2023 Q1	$764M	Hold	7,000,000	–	–	11.33%	1
2022 Q4	$797M	Buy	7,000,000 +1,875,000	+37%	+$213M	11.9%	2
2022 Q3	$317M	Buy	5,125,000 +125,000	+3%	+$7.74M	5.86%	6
2022 Q2	$399M	Sell	5,000,000 -1,500,000	-23%	-$120M	7.88%	4
2022 Q1	$684M	Sell	6,500,000 -2,795,000	-30%	-$294M	12.48%	1
2021 Q4	$1B	Buy	9,295,000 +295,000	+3%	+$31.8M	17.05%	1
2021 Q3	$986M	Hold	9,000,000	–	–	15.49%	1
2021 Q2	$843M	Hold	9,000,000	–	–	14.66%	1
2021 Q1	$828M	Hold	9,000,000	–	–	14.31%	1
2020 Q4	$658M	Buy	9,000,000 +1,350,000	+18%	+$98.8M	11.34%	2
2020 Q3	$594M	Buy	7,650,000 +1,650,000	+28%	+$128M	8.44%	3
2020 Q2	$333M	Buy	6,000,000 +1,425,000	+31%	+$79.2M	6.59%	3
2020 Q1	$136M	Buy	4,575,000 +575,000	+14%	+$17M	4.57%	7
2019 Q4	$145M	Hold	4,000,000	–	–	4.25%	9
2019 Q3	$109M	Hold	4,000,000	–	–	4.54%	8
2019 Q2	$96.2M	Hold	4,000,000	–	–	3.33%	11
2019 Q1	$106M	Sell	4,000,000 -350,000	-8%	-$9.25M	4.57%	7
2018 Q4	$85M	Sell	4,350,000 -110,426	-2%	-$2.16M	5.08%	8
2018 Q3	$87.3M	Sell	4,460,426 -1,133,257	-20%	-$22.2M	4.01%	10
2018 Q2	$92.6M	Buy	5,593,683 +435,000	+8%	+$7.2M	3.57%	9
2018 Q1	$73.3M	Buy	5,158,683 +722,500	+16%	+$10.3M	3.5%	10
2017 Q4	$64.8M	Buy	4,436,183 +920,083	+26%	+$13.4M	4.2%	10
2017 Q3	$44.6M	Buy	+3,516,100	New	+$44.6M	3.46%	10